XML 9 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 213,944 $ 199,252
Restricted cash 525 525
Short-term investments 94,235 121,407
Accounts receivable, net 115,806 133,563
Inventory 255,280 258,616
Prepaid and other current assets 8,142 11,618
Total current assets 687,932 724,981
Property, plant and equipment, net 81 114
Long-term inventory 74,225 77,615
Operating lease right-of-use asset 7,876 8,310
Other long-term assets 1,324 1,360
Intangible asset, net 18,575 19,304
TOTAL ASSETS 790,013 831,684
Current Liabilities:    
Accounts payable 67,600 52,762
Accrued expenses and other current liabilities 154,440 204,174
Current deferred revenue 2,341 2,341
Total current liabilities 224,381 259,277
Long-Term Liabilities:    
Long-term deferred revenue 2,108 2,509
Long-term operating lease liability 8,389 8,737
Other long-term liabilities 9,199 9,064
Total liabilities 244,077 279,587
Commitments and contingencies (Note 5)
Stockholders’ Equity:    
Common stock, GBP 0.50 par, unlimited authorized; 421,270,432 shares issued, 410,735,780 shares outstanding as of March 31, 2024; 418,141,295 shares issued, 408,824,093 shares outstanding as of December 31, 2023 304,742 302,756
Additional paid-in capital 1,902,698 1,899,456
Treasury stock; 10,534,652 shares as of March 31, 2024; 9,317,202 shares as of December 31, 2023 (65,188) (63,752)
Accumulated deficit (1,596,316) (1,586,363)
Total stockholders’ equity 545,936 552,097
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 790,013 $ 831,684